A Case Study on Hereditary Angioedema[HAE]
Abstract
Hereditary angioedema (HAE) is a rare genetic disorder characterized by recurrent episodes of localized swelling in various parts of the body. This case study provides an in-depth analysis of a patient diagnosed with hereditary angioedema, focusing on the clinical presentation, pathophysiology, diagnostic approaches, treatment modalities, and impact on the patient's quality of life. The case study details the medical history of a 28-year-old female presenting with recurrent episodes of non-pruritic swelling in the extremities, face, and abdominal region. Through a thorough examination and laboratory investigations, including complement testing and genetic analysis, a definitive diagnosis of hereditary angioedema type I was established.The pathophysiology section explores the underlying mechanism of HAE, emphasizing the deficiency or dysfunction of the C1 inhibitor protein, leading to unregulated activation of the bradykinin pathway and subsequent vasodilation and increased vascular permeability.Diagnostic challenges and considerations are discussed, highlighting the importance of differentiating HAE from other forms of angioedema and implementing appropriate laboratory tests for accurate diagnosis.Treatment strategies, including on-demand therapies and prophylactic options, such as C1 inhibitor replacement therapy and bradykinin receptor antagonists, are thoroughly reviewed. The study also addresses the patient's psychosocial aspects, emphasizing the impact of HAE on daily life activities, emotional well-being, and the necessity for holistic patient care. In conclusion, this case study contributes to a better understanding of hereditary angioedema, emphasizing the significance of early recognition, accurate diagnosis, and tailored management strategies to improve the quality of life for individuals affected by this rare genetic disorder.
Downloads
References
2. Rosen FS, Pensky J, Donaldson V, Charache P. Hereditary angioneurotic edema: two genetic variants. Science 1965;148:957-958.
3. Bork K, Barnstedt SE, Koch P, Traupe H. Hereditary angioedema with normal C1-inhibitor activity in women. Lancet 2000;356:213-217.
4. Zuraw BL. Hereditary angioedema. N Engl J Med 2008;359:1027-1036.
5. Kusuma A, Relan A, Knulst AC, et al. Clinical impact of peripheral attacks in hereditary angioedema patients. Am J Med 2012;125(9):937.e17-24.

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.